Inventor · disambiguated record
John Freund
Also filed as: FREUND JOHN · FREUND JOHN M
8 granted patents·5 pending applications·34 citations·filing 2010–2024
82Inventor score
Files withARIXA PHARMACEUTICALS INC11BADYLAK STEPHEN F1UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION1
Top patents by PatentIndex Score
13 records- 0197US10085999B1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted Oct 2, 2018·16 cites·30 claims
- 0292US10280161B2Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted May 7, 2019·5 cites·27 claims
- 0387US9814744B2Decellularized adipose cell growth scaffoldBADYLAK STEPHEN F·Filed 2010·Granted Nov 14, 2017·12 cites·9 claims
- 0487US2024415847A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0582US10722521B2Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·1 cites·24 claims
- 0682US2023201218A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0768US10500211B2Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2018·Granted Dec 10, 2019·0 cites·26 claims
- 0868US2020297733A1Beta-lactamase inhibitors and uses thereofARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0963US10815228B2Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·29 claims
- 1062US2021009580A1Aztreonam derivatives and uses thereofARIXA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1154US2018125897A1Decellularized Adipose Cell Growth ScaffoldUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2017·Application pending·0 cites
- 1251US11565999B2Methods of synthesizing aztreonam derivativesARIXA PHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·0 cites·6 claims
- 1348US11180500B2Derivatives of relebactam and uses thereofARIXA PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →